WELL Health Technologies Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

WELL Health TechnologiesDer Gewinn des Unternehmens wird voraussichtlich um 102.9% pro Jahr sinken, während der Jahresumsatz voraussichtlich um 10.4% pro Jahr wachsen wird. Der Gewinn pro Aktie wird voraussichtlich zurückgehen.

Wichtige Informationen

-102.9%

Wachstumsrate der Gewinne

-134.2%

EPS-Wachstumsrate

Healthcare Gewinnwachstum	86.5%
Wachstumsrate der Einnahmen	10.4%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Good
Zuletzt aktualisiert	21 Jun 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 60% Above Its Share Price

Jun 11

WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 43% Above Its Share Price

May 31

Gewinn- und Umsatzwachstumsprognosen

TSX:WELL - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (CAD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	1,149	N/A	76	N/A	2
12/31/2025	1,070	4	82	112	13
12/31/2024	972	6	65	97	14
3/31/2024	838	30	49	68	N/A
12/31/2023	776	0	41	66	N/A
9/30/2023	701	-7	60	81	N/A
6/30/2023	643	-4	61	76	N/A
3/31/2023	612	-5	67	81	N/A
12/31/2022	569	1	70	77	N/A
9/30/2022	528	-29	20	56	N/A
6/30/2022	482	-37	5	49	N/A
3/31/2022	403	-45	-19	34	N/A
12/31/2021	302	-44	-30	22	N/A
9/30/2021	204	-29	-13	10	N/A
6/30/2021	117	-21	-10	2	N/A
3/31/2021	66	-9	-4	-4	N/A
12/31/2020	50	-4	-7	-5	N/A
9/30/2020	43	-9	-5	-4	N/A
6/30/2020	39	-10	-4	-3	N/A
3/31/2020	36	-8	-4	-3	N/A
12/31/2019	33	-8	-3	-3	N/A
12/31/2018	9	-2	-1	-1	N/A
10/31/2018	6	-2	-1	-1	N/A
7/31/2018	4	-6	-1	-1	N/A
4/30/2018	2	-6	-1	-1	N/A
1/31/2018	0	-6	N/A	-1	N/A
10/31/2017	N/A	-1	N/A	-1	N/A
7/31/2017	0	-1	N/A	-1	N/A
3/31/2017	0	0	N/A	-1	N/A
12/31/2016	0	0	N/A	0	N/A
10/31/2016	0	-1	N/A	0	N/A
12/31/2015	0	-1	N/A	0	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: WELLFür die nächsten 3 Jahre wird ein Rückgang der Gewinne prognostiziert (-102.9% pro Jahr).

Ertrag vs. Markt: WELLFür die nächsten 3 Jahre wird ein Rückgang der Gewinne prognostiziert (-102.9% pro Jahr).

Hohe Wachstumserträge: WELLFür die nächsten 3 Jahre wird mit einem Rückgang der Erträge gerechnet.

Einnahmen vs. Markt: WELLDie Einnahmen des Unternehmens (10.1% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Canadian (7.3% pro Jahr).

Hohe Wachstumseinnahmen: WELLDie Einnahmen des Unternehmens (10.1% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von WELL in 3 Jahren voraussichtlich hoch sein wird

WELL Health Technologies Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

WELL Health Technologies Corp. Revises Revenue Guidance for the Year 2024

Well Health Technologies Corp. Raises Earnings Guidance for 2024

Well Health Technologies Corp. Provides Earnings Guidance for the Year 2023 and 2024

Consensus EPS estimates upgraded to CA$0.08 loss

Consensus estimates of losses per share improve by 22%

Consensus EPS estimates fall by 11%, revenue upgraded

Recent updates

New major risk - Revenue and earnings growth

WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 60% Above Its Share Price

WELL Health Technologies' (TSE:WELL) Earnings Are Weaker Than They Seem

WELL Health Technologies Corp. Revises Revenue Guidance for the Year 2024

WELL Health Technologies Corp. to Report Q1, 2024 Results on May 08, 2024

WELL Health Technologies Corp., Annual General Meeting, Jun 12, 2024

Well Health Technologies Corp. Raises Earnings Guidance for 2024

Full year 2023 earnings released: EPS: CA$0 (vs CA$0.006 in FY 2022)

WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

WELL Health Technologies Corp. to Report Q4, 2023 Results on Mar 21, 2024

Is WELL Health Technologies Corp. (TSE:WELL) Trading At A 40% Discount?

Independent Director exercised options and sold CA$144k worth of stock

WELL Health Technologies Corp. Announces the Creation of A Dedicated Public Sector Group to Help Tech Enable Public Health Systems Operating At Scale

Healwell AI Inc. (TSX:AIDX) completed the acquisition of Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

Healwell AI Inc. (TSX:AIDX) entered into an agreement to acquire Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

The Price Is Right For WELL Health Technologies Corp. (TSE:WELL)

WELL Health Technologies Corp. announced that it has received CAD 0.074876 million in funding

Well Health Announces Launch of Well Ai Inbox Admin: A Revolutionary Ai-Powered Solution for Clinic Inbox Management

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Well Health Technologies Corp. Provides Earnings Guidance for the Year 2023 and 2024

Consensus EPS estimates upgraded to CA$0.08 loss

WELL Health Technologies Corp. Launches WELL Longevity+ Program

WELL Health Technologies Corp. to Report Q3, 2023 Results on Nov 14, 2023

WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

Independent Director recently sold CA$160k worth of stock

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of Clinic assets from MCI Medical Clinics Inc.

Consensus estimates of losses per share improve by 22%

Second quarter 2023 earnings: EPS exceeds analyst expectations

WELL Health Technologies Corp. to Report Q2, 2023 Results on Aug 10, 2023

Founder exercised options and sold CA$527k worth of stock

WELL Health Technologies Corp. (TSX:WELL) entered into an agreement to acquire Significant Portion of Clinical Assets of MCI Medical clinics Inc.

Consensus EPS estimates fall by 11%, revenue upgraded

We Think WELL Health Technologies (TSE:WELL) Can Stay On Top Of Its Debt

Consensus EPS estimates fall by 11%, revenue upgraded

Well Health Technologies Corp. Provides Revenue Guidance for the Year 2023

Chief Financial Officer exercised options to buy CA$1.5m worth of stock.

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of MCI Medical Clinics (Alberta) Inc. from MCI Onehealth Technologies Inc. (TSX:DRDR).

Founder exercised options and sold CA$204k worth of stock

Consensus EPS estimates fall by 60%

WELL Health Technologies Corp. (TSX:WELL) entered into a definitive share purchase agreement to acquire MCI Medical Clinics (Alberta) Inc. from MCI Onehealth Technologies Inc. (TSX:DRDR) for CAD 2 million.

Consensus EPS estimates fall by 108%, revenue upgraded

WELL Health Technologies Corp. Provides Earnings Guidance for the Year 2023

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

WELL Health Technologies Corp. Announces the Launch of Its Ground-Breaking Product, WELL AI Voice

WELL Health Technologies Corp. to Report Q1, 2023 Results on May 12, 2023

WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

Full year 2022 earnings released: EPS: CA$0.006 (vs CA$0.23 loss in FY 2021)

Consensus EPS estimates fall by 77%

Are Investors Undervaluing WELL Health Technologies Corp. (TSE:WELL) By 40%?

Consensus estimates of losses per share improve by 24%

Forecast to breakeven in 2024

Forecast to breakeven in 2024

Third quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

WELL Health Technologies Corp. Increases Annual Revenue Guidance for 2022

Should You Think About Buying WELL Health Technologies Corp. (TSE:WELL) Now?

WELL Health Technologies Corp. to Report Q3, 2022 Results on Nov 10, 2022

Independent Director recently sold CA$357k worth of stock

Consensus forecasts updated

WELL Health Technologies Corp. (TSX:WELL) entered into an agreement to acquire Cloud Practice Inc. and 3 Clinics from CloudMD Software & Services Inc. (TSXV:DOC) for CAD 5.75 million.

Independent Director recently sold CA$153k worth of stock

Independent Director exercised options to buy CA$818k worth of stock.

No longer forecast to breakeven

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

WELL Health Technologies Corp. Updates Revenue Guidance for the Year of 2022

Consensus forecasts updated

Is WELL Health Technologies Corp. (TSE:WELL) Potentially Undervalued?

WELL Health Technologies Corp. Announces Appointment of Sybil Lau to its Board of Directors

Consensus forecasts updated

WELL Health Technologies Corp. Provides Revenue Guidance for the Second Quarter 2022